Detalles de la búsqueda
1.
Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors.
Mod Pathol
; 27(11): 1510-20, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24743220
2.
In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor.
Biomedicines
; 10(5)2022 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625872
3.
Integrating Duodenal Sampling in a Human Mass Balance Study to Quantify the Elimination Pathways of JNJ-53718678, a Respiratory Syncytial Virus Fusion Protein Inhibitor.
Adv Ther
; 37(1): 578-591, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31832988
4.
Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations.
Mol Cancer Ther
; 15(12): 2845-2852, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27777285
5.
Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models.
Transl Oncol
; 8(2): 112-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926077
6.
Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors.
Clin Sarcoma Res
; 4: 10, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25132955
7.
Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models.
Transl Oncol
; 7(6): 665-71, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25500074
8.
Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacy.
Clin Cancer Res
; 20(23): 6071-82, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316817
9.
A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal.
Clin Cancer Res
; 19(3): 620-30, 2013 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23231951
10.
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models.
Mol Cancer Ther
; 11(8): 1799-808, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22714264
11.
The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations.
Clin Cancer Res
; 17(17): 5604-14, 2011 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21737509
Resultados
1 -
11
de 11
1
Próxima >
>>